LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. LifeScienceXchange multiplies the impact of biologics and immunotherapy R&D, bringing new treatments to patients faster.

Latest News and Commentary

Top 25 of ’25: NextGen Biomed eBook

Top 25 of ’25: NextGen Biomed eBook

Curated insight from the leaders shaping biologics and immunotherapy
News
Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Tom Cohen Digital Publisher, Oxford Global
News
Three Innovations for Green and Controlled Peptide Manufacture
Technology Spotlight PolyPeptide Group

Three Innovations for Green and Controlled Peptide Manufacture

Fabien Rousset Director Global Innovation, PolyPeptide
Technology Spotlight
Peptides
Market Insight

The Digital Transformation of Oligonuleotide Development

Martin Olbrich Principal Scientist, Process Research, Roche
Market Insight
Oligonucleotides
Market Insight

Targeting Melanoma with the SCIB1 Vaccine

Samantha Paston Head of Translational Research, Scancell
Market Insight
Vaccines
NGB LSX - Connect with Peers

Latest Technology Spotlights
Interview with Mingjie Xie, Chief Executive Officer, Rapid Novor

Interview with Mingjie Xie, Chief Executive Officer, Rapid Novor

Proteins, Antibodies & ADCs
Apr, 2026
Interview with James Keck, Vice President of Innovation and Product Development, The Jackson Laboratory

Interview with James Keck, Vice President of Innovation and Product Development, The Jackson Laboratory

Cell & Gene
Apr, 2026
A Novel Engineered CHO Host Cell Line For High-Titer Production Of Biopharmaceuticals

A Novel Engineered CHO Host Cell Line For High-Titer Production Of Biopharmaceuticals

Cell & Gene
Nov, 2025
One Reactor To Rule Them All: A Novel Bionic Bioreactor for Sensitive Stem & Immune-Cells

One Reactor To Rule Them All: A Novel Bionic Bioreactor for Sensitive Stem & Immune-Cells

Cell & Gene
Nov, 2025

Latest News

See all
Interview with Ilse Roodink, CSO, AVS Bio

Interview with Ilse Roodink, CSO, AVS Bio

Apr, 2026
Interview with Nick Challoner, CEO, Ingenza

Interview with Nick Challoner, CEO, Ingenza

Apr, 2026
Interview with Charlotte Deane

Interview with Charlotte Deane

Proteins, Antibodies & ADCs
Mar, 2026

Thought Leadership

Interview with Hans Melo

Hans Melo Co-Founder & Chief Executive Officer, Menten AI
Peptides
Mar, 2026

Interview with Karen Silence

Karen Silence Vice President, argenx
Proteins, Antibodies & ADCs
Mar, 2026

Interview with Alexander Eggermont

Alexander Eggermont Professor Immunotherapy of Cancer, Utrecht University
Cell & Gene
Feb, 2026

Market Insight: Across Modalities

An All Stakeholder Approach To Cell & Gene Therapy

Cell & Gene
Nov, 2025

Scaling Up Complex Organoid Models: Challenges And Solutions

Cell & Gene
Nov, 2025

Challenges and Solutions in the Purification of Oligonucleotides

Oligonucleotides
Apr, 2025

Protein Corona and Freeze-Thaw Stability in Lipid Nanoparticles

Oligonucleotides
Apr, 2025

Pre-Clinical Considerations For Development Of ADCs

Proteins, Antibodies & ADCs
Oct, 2025

How ‘Proximity Medicines’ Are Transforming Pharmacotherapy

Proteins, Antibodies & ADCs
Oct, 2025

Snakebite Medicines: Venom Derived Peptides for Therapeutic Indications

Peptides
May, 2025

AI-Powered Peptide Design: Transforming Drug Discovery with Machine Learning

Peptides
May, 2025

Cell-Free Cancer Vaccines Developed in Two Weeks

Vaccines
May, 2025

Potency Testing in RNA Therapeutics

Vaccines
May, 2025

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.